Purificación Martínez del Prado
Hospital de Basurto(ES)GEICAM – Spanish Breast Cancer Group(ES)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Venous Thromboembolism Diagnosis and Management, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies
Most-Cited Works
- → Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen(2006)204 cited
- → Risk-Adapted Treatment in Clinical Stage I Testicular Seminoma: The Third Spanish Germ Cell Cancer Group Study(2011)127 cited
- → First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the On study(2010)88 cited
- → Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non–Small-Cell Lung Cancer(2023)75 cited
- → Prognostic Factors and Long-Term Outcome of Pancreatic Neuroendocrine Neoplasms: Ki-67 Index Shows a Greater Impact on Survival than Disease Stage. The Large Experience of the Spanish National Tumor Registry (RGETNE)(2013)71 cited
- → Functional proteomics outlines the complexity of breast cancer molecular subtypes